Welcome!

News Feed Item

USC Eye Institute ophthalmologists implant first FDA-approved Argus II retinal prosthesis in western United States

Keck Medicine of USC patient sees for first time in 30 years only one week after implant

LOS ANGELES, Aug. 27, 2014 /PRNewswire/ -- Lisa Kulik saw fireworks for the first time in nearly 30 years this July 4 holiday, thanks to a groundbreaking retinal implant co-invented by Mark Humayun, M.D., Ph.D., an internationally renowned clinician-researcher at the University of Southern California (USC) Eye Institute.

Kulik is a 55-year-old Peoria, Ariz. resident who has retinitis pigmentosa, a degenerative disease that progressively robs its victims of sight. On June 2, she became the first person west of the Mississippi to receive the FDA-approved Argus II retinal prosthesis, innovative wireless technology co-invented by Humayun, who is the Cornelius Pings Professor of Biomedical Sciences and professor of ophthalmology, biomedical engineering, cell and neurobiology at Keck Medicine of USC and the USC Viterbi School of Engineering.

When Kulik wore the Argus II to the July 4 celebration with her husband and niece, she didn't expect to see anything. But when the fireworks went off, so did flashes in her field of vision.

"My husband and niece were more excited than I was," she said. "I was seeing thick and thin flashes, and I knew it was the fireworks. I've also seen the moon, and I can see the contrast between the grass and the sidewalk.

"I'm hoping I will be able to see silhouettes of people, like my grandchildren, and be able to get around by myself. Losing independence has been the hardest part [of being blind] for me. I'd like to be able to take a walk down the street."

Kulik's progress is encouraging to Humayun, who started developing the Argus II more than 20 years ago.

"She could see spots of light on the first day of activation, which is very exciting," said Humayun, who is professor of ophthalmology and biomedical engineering at USC and co-director of the USC Eye Institute. The USC Eye Institute has ranked as a Top 10 ophthalmology program for 24 years and is No. 3 in research funding from the National Eye Institute. "That put her ahead of our expectations. Most of our patients haven't seen for decades and they have to relearn how to interpret visual signals, which takes quite a while. It's like seeing a baby learn to crawl, then to walk, then to run."

Kulik received the implant during a four-hour surgery at Keck Medicine of USC, performed by Lisa Olmos de Koo, assistant professor of ophthalmology at the Keck School, with Humayun assisting. Kulik is now undergoing several months of follow-up testing while she trains her brain to see in a new way. Some Argus II patients can see contrast well enough to sort light and dark clothing, and to see the outlines of doors, bushes, people and other objects.

The Argus II system uses a camera mounted on special glasses that sends a signal to an electronic receiver with 60 electrodes implanted inside the eye. The receiver sends signals to the retina that travel through the optic nerve to the brain, where they can be interpreted as a visual picture. Future applications of the device are aimed at age-related macular degeneration, a similar but more common disease than RP. The prosthesis is manufactured and sold by Second Sight Medical Products in Sylmar, California.

Clinical trials for the Argus II at USC began in 2007, with more than 30 patients implanted with the device as part of the trial. Eligible patients must be over the age of 25, have little or no light perception in both eyes and have had previous sight.

The Argus II is not just a professional goal for Humayun. As a medical school student, he was inspired to study blindness when complications from diabetes stole his grandmother's sight, and nothing could be done to help her.

"As her vision deteriorated, it was sad to see her losing the enjoyment she got through reading and being in her garden," he said. "That experience made me reconsider my path in medicine, and I obtained a Ph.D. in engineering so I could help restore sight to blind people."

Kulik began losing her sight in her late 20s, and by her early 30s, all she could see were shadows in extremely bright conditions. She had to give up her driver's license and quit her job at a veterinary clinic, working with the animals she loved. And she missed seeing her two sons, now 31 and 24, become men.

Her journey toward sight began in 2012, when her husband Ed saw an article on the Internet about the Argus II.  Kulik said Ed's discovery confirmed her continuous optimism that a solution to her blindness would be found.

"When I was diagnosed, I didn't let it stop me," she said. "I knew someone would come up with something."

Innovation is one of the hallmarks of the USC Eye Institute, a leader in National Eye Institute funding and ranked No. 9 in the United States for ophthalmology care by U.S. News & World Report. The Argus II is one of many examples of how the interdisciplinary environment at USC enables the creation of potential miracle solutions to health problems.

"One of USC's strengths is that we have an extraordinarily collaborative environment with world-class expertise in many different areas that can impact our health — including medicine, engineering, pharmacy, interactive media and public policy," said Rohit Varma, M.D., M.P.H., director of the USC Eye Institute and chair, Department of Ophthalmology, Keck School of Medicine of USC. "The Argus II is one of the prime examples of such a collaboration, resulting from a strong relationship with the Keck School of Medicine of USC and the USC Viterbi School of Engineering. 

"Losing sight is devastating to most people, making them depressed, more dependent on others and reducing their social interactions and productivity, among other things," Varma added. "Now with the Argus II we have the potential to reverse all that and help people begin new, more independent, productive and fuller lives. By bringing sight back to the blind, the Argus II is truly a miracle."

Retinitis pigmentosa (RP) is a genetic disease affecting nearly 100,000 people in the U.S. Those with the disease experience progressive loss of photoreceptors (rods and cones) or the retinal pigment epithelium, a pigmented cell layer that nourishes retinal cells. As the disease progresses, patients experience night blindness, tunnel vision, blurring, and difficulty adjusting from dark to light environments. Eventually their vision is reduced to shadows and most victims are declared legally blind.

Kulik is also participating in a study to determine whether partial restoration of vision has an impact on how the brain processes information. She returns to USC periodically for magnetic imaging resonation (MRI) tests, as well as testing with the Argus II.

ABOUT USC EYE INSTITUTE:
The USC Eye Institute has consistently ranked as a Top 10 ophthalmology program by U.S. News & World Report and Ophthalmology Times and is No. 3 in research funding from the National Eye Institute. Led by Rohit Varma, M.D., M.P.H., the USC Eye Institute has 21 full-time faculty physicians covering all subspecialties of ophthalmology. The USC Eye Institute is headquartered near downtown Los Angeles and has satellite clinics in Pasadena, Beverly Hills and Arcadia. For more information, go to eye.keckmedicine.org.

ABOUT KECK MEDICINE OF USC
Keck Medicine of USC is the University of Southern California's medical enterprise, one of only two university-based medical systems in the Los Angeles area. Encompassing academic, research and clinical excellence, the medical system attracts internationally renowned experts who teach and practice at the Keck School of Medicine of USC, the region's first medical school; includes the renowned USC Norris Comprehensive Cancer Center, one of the first comprehensive cancer centers established by the National Institutes of Health (NIH) in the United States; has a medical faculty practice, the USC Care Medical Group; operates the Keck Medical Center of USC, which includes two acute care hospitals: 401-licensed bed Keck Hospital of USC and 60-licensed bed USC Norris Cancer Hospital; and owns USC Verdugo Hills Hospital, a 158-licensed bed community hospital. It also includes more than 40 outpatient facilities, some at affiliated hospitals, in Los Angeles, Orange, Kern, Tulare and Ventura counties. For more information, go to www.keckmedicine.org/beyond

Video available at https://www.youtube.com/watch?v=wFUwJZ2aL6I

B-roll available on request

University of Southern California logo.

SOURCE Keck Medicine of USC

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
StackIQ has announced the release of Stacki 3.2. Stacki is an easy-to-use Linux server provisioning tool. Stacki 3.2 delivers new capabilities that simplify the automation and integration of site-specific requirements. StackIQ is the commercial entity behind this open source bare metal provisioning tool. Since the release of Stacki in June of 2015, the Stacki core team has been focused on making the Community Edition meet the needs of members of the community, adding features and value, while ...
Qosmos has announced new milestones in the detection of encrypted traffic and in protocol signature coverage. Qosmos latest software can accurately classify traffic encrypted with SSL/TLS (e.g., Google, Facebook, WhatsApp), P2P traffic (e.g., BitTorrent, MuTorrent, Vuze), and Skype, while preserving the privacy of communication content. These new classification techniques mean that traffic optimization, policy enforcement, and user experience are largely unaffected by encryption. In respect wit...
For basic one-to-one voice or video calling solutions, WebRTC has proven to be a very powerful technology. Although WebRTC’s core functionality is to provide secure, real-time p2p media streaming, leveraging native platform features and server-side components brings up new communication capabilities for web and native mobile applications, allowing for advanced multi-user use cases such as video broadcasting, conferencing, and media recording.
SYS-CON Events announced today the Kubernetes and Google Container Engine Workshop, being held November 3, 2016, in conjunction with @DevOpsSummit at 19th Cloud Expo at the Santa Clara Convention Center in Santa Clara, CA. This workshop led by Sebastian Scheele introduces participants to Kubernetes and Google Container Engine (GKE). Through a combination of instructor-led presentations, demonstrations, and hands-on labs, students learn the key concepts and practices for deploying and maintainin...
SYS-CON Events announced today that Venafi, the Immune System for the Internet™ and the leading provider of Next Generation Trust Protection, will exhibit at @DevOpsSummit at 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Venafi is the Immune System for the Internet™ that protects the foundation of all cybersecurity – cryptographic keys and digital certificates – so they can’t be misused by bad guys in attacks...
ReadyTalk has expanded the capabilities of the FoxDen collaboration platform announced late last year to include FoxDen Connect, an in-room video collaboration experience that launches with a single touch. With FoxDen Connect, users can now not only engage in HD video conferencing between iOS and Android mobile devices or Chrome browsers, but also set up in-person meeting rooms for video interactions. A host’s mobile device automatically recognizes the presence of a meeting room via beacon tech...
The cloud market growth today is largely in public clouds. While there is a lot of spend in IT departments in virtualization, these aren’t yet translating into a true “cloud” experience within the enterprise. What is stopping the growth of the “private cloud” market? In his general session at 18th Cloud Expo, Nara Rajagopalan, CEO of Accelerite, explored the challenges in deploying, managing, and getting adoption for a private cloud within an enterprise. What are the key differences between wh...
Deploying applications in hybrid cloud environments is hard work. Your team spends most of the time maintaining your infrastructure, configuring dev/test and production environments, and deploying applications across environments – which can be both time consuming and error prone. But what if you could automate provisioning and deployment to deliver error free environments faster? What could you do with your free time?
Ixia (Nasdaq: XXIA) has announced that NoviFlow Inc.has deployed IxNetwork® to validate the company’s designs and accelerate the delivery of its proven, reliable products. Based in Montréal, NoviFlow Inc. supports network carriers, hyperscale data center operators, and enterprises seeking greater network control and flexibility, network scalability, and the capacity to handle extremely large numbers of flows, while maintaining maximum network performance. To meet these requirements, NoviFlow in...
Choosing the right cloud for your workloads is a balancing act that can cost your organization time, money and aggravation - unless you get it right the first time. Economics, speed, performance, accessibility, administrative needs and security all play a vital role in dictating your approach to the cloud. Without knowing the right questions to ask, you could wind up paying for capacity you'll never need or underestimating the resources required to run your applications.
It’s 2016: buildings are smart, connected and the IoT is fundamentally altering how control and operating systems work and speak to each other. Platforms across the enterprise are networked via inexpensive sensors to collect massive amounts of data for analytics, information management, and insights that can be used to continuously improve operations. In his session at @ThingsExpo, Brian Chemel, Co-Founder and CTO of Digital Lumens, will explore: The benefits sensor-networked systems bring to ...
Extreme Computing is the ability to leverage highly performant infrastructure and software to accelerate Big Data, machine learning, HPC, and Enterprise applications. High IOPS Storage, low-latency networks, in-memory databases, GPUs and other parallel accelerators are being used to achieve faster results and help businesses make better decisions. In his session at 18th Cloud Expo, Michael O'Neill, Strategic Business Development at NVIDIA, focused on some of the unique ways extreme computing is...
On Dice.com, the number of job postings asking for skill in Amazon Web Services increased 76 percent between June 2015 and June 2016. Salesforce.com saw its own skill mentions increase 37 percent, while DevOps and Cloud rose 35 percent and 28 percent, respectively. Even as they expand their presence in the cloud, companies are also looking for tech professionals who can manage projects, crunch data, and figure out how to make systems run more autonomously. Mentions of ‘data science’ as a skill ...
Cloud analytics is dramatically altering business intelligence. Some businesses will capitalize on these promising new technologies and gain key insights that’ll help them gain competitive advantage. And others won’t. Whether you’re a business leader, an IT manager, or an analyst, we want to help you and the people you need to influence with a free copy of “Cloud Analytics for Dummies,” the essential guide to this explosive new space for business intelligence.
Manufacturers are embracing the Industrial Internet the same way consumers are leveraging Fitbits – to improve overall health and wellness. Both can provide consistent measurement, visibility, and suggest performance improvements customized to help reach goals. Fitbit users can view real-time data and make adjustments to increase their activity. In his session at @ThingsExpo, Mark Bernardo Professional Services Leader, Americas, at GE Digital, discussed how leveraging the Industrial Internet a...